Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure.
作者信息
Docherty Kieran F, Petrie Mark C
机构信息
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
出版信息
Heart. 2022 Feb;108(4):312-320. doi: 10.1136/heartjnl-2020-318658. Epub 2021 Jun 14.
PMID:34127540
Abstract
摘要
相似文献
1
Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure.
Heart. 2022 Feb;108(4):312-320. doi: 10.1136/heartjnl-2020-318658. Epub 2021 Jun 14.
2
Treatment with sodium-glucose cotransporter-2 inhibitors in heart failure patients: The potential benefits of monitoring FGF-23 levels?
Ann Endocrinol (Paris). 2022 Feb;83(1):78-80. doi: 10.1016/j.ando.2021.10.003. Epub 2021 Oct 30.
3
Sodium-glucose cotransporter 2 inhibitors in hospitalized heart failure patients: No time like now.
Eur J Heart Fail. 2023 Oct;25(10):1806-1807. doi: 10.1002/ejhf.3022. Epub 2023 Sep 10.
4
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
Circulation. 2019 Nov 5;140(19):1569-1577. doi: 10.1161/CIRCULATIONAHA.119.042685. Epub 2019 Aug 31.
5
Time-varying effects of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: An updated meta-analysis.
J Evid Based Med. 2024 Mar;17(1):13-16. doi: 10.1111/jebm.12597. Epub 2024 Mar 11.
6
Meta-Analysis of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure Patients Without Diabetes.
Am J Cardiol. 2021 Jun 1;148:175-176. doi: 10.1016/j.amjcard.2021.03.001. Epub 2021 Mar 6.
7
Barcelona Bio-HF calculator version 3.0: recalibration and incorporation of sodium-glucose cotransporter 2 inhibitor treatment.
Eur J Heart Fail. 2023 Jan;25(1):131-132. doi: 10.1002/ejhf.2752. Epub 2022 Dec 20.
8
Treatment of heart failure with sodium glucose co-transporter-2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.
Diabet Med. 2019 Dec;36(12):1550-1561. doi: 10.1111/dme.14140. Epub 2019 Oct 10.
9
The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?
Circulation. 2017 Oct 17;136(16):1459-1461. doi: 10.1161/CIRCULATIONAHA.117.029284.
10
The frail patient and the frailing heart. Letter regarding the article 'Barcelona Bio-HF calculator version 3.0: recalibration and incorporation of sodium-glucose cotransporter 2 inhibitor treatment'.
Eur J Heart Fail. 2023 Mar;25(3):441. doi: 10.1002/ejhf.2784. Epub 2023 Feb 2.
Zotero 插件